Global Health: Gilead Will Donate Truvada to U.S. for H.I.V. Prevention
The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives. [Source]
Publication Date:Origin: nytimes.com
Category: Acquired Immune Deficiency Syndrome
Topics: enough, motives, company’s, questioned, epidemic, would, Critics, decade, annually, patients, supply, provide, manufacturer, Prevention, Truvada, Donate, Gilead, Health, Global
Source: https://www.nytimes.com/2019/05/09/health/gilead-truvada-hiv-aids.html?partner=rss&emc=rss